ClinicalTrials.gg
Sign In

Cardiomyopathies clinical trials

The registry lists 553 studies for Cardiomyopathies across more than 10 countries. 152 are recruiting or about to start. 196 of them are mainly about Cardiomyopathies (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 8 narrower conditions too, such as Cardiomyopathy, Hypertrophic: 1,389 studies, 396 open.

ClinicalTrials.gov finds 1,903 studies for Cardiomyopathies. How that becomes 552 here

This page counts the studies the registry files under Cardiomyopathies, and those it files under no condition that list Cardiomyopathiesthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 1,903Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −816Filed under a narrower condition, counted on its own pageCardiomyopathy, Hypertrophic 323 · Cardiomyopathy, Dilated 179 · Myocarditis 119 · Myocardial Reperfusion Injury 56 · Takotsubo Cardiomyopathy 53 · Diabetic Cardiomyopathies 27 · 2 more
  3. −307List Cardiomyopathies as a condition, but the registry did not file them under itMost often written as “Ischemic Cardiomyopathy” (89), “Non-ischemic Cardiomyopathy” (21), and “Transthyretin Amyloid Cardiomyopathy” (19). The registry filed 83 of them under no condition at all, and the others under other conditions only, most often Heart Failure (75) and Amyloid Neuropathies, Familial (30).
  4. −228Match it another way144 name it in the title, 51 in a keyword, and 33 by a synonym or other text the search reads.
  5. 552The count on this page

Get an email when these change. Save the Cardiomyopathies studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
257
Recruiting
116
Status unknown
70
Terminated
29
Active, not recruiting
25
Not yet recruiting
24

Phase

Phase 2
53
Phase 1
47
Phase 3
43
Phase 4
28
Early Phase 1
2

Where

United States
230
Germany
63
France
51
United Kingdom
50
Italy
49
Canada
43

Who runs them

National Heart, Lung, and Blood Institute (NHLBI) (14) · Mayo Clinic (11) · Assistance Publique - Hôpitaux de Paris (10) · Alnylam Pharmaceuticals (9) · Emory University (8) · Abbott Medical Devices (8) · University Hospital, Bonn (6) · Lexeo Therapeutics (6)

What is being tested here

Drugs under test in Cardiomyopathies studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Acoramidis335
Melatonin212
Carvedilol104
Vutrisiran122
HRS-1893102
NTLA-2001112
Deferoxamine102
Nicorandil101
Selenium101
MYK-461101

Drug classes tested here Beta blockers 1 open · SGLT2 inhibitors 1 open · Mineralocorticoid receptor antagonists (MRAs) 4 · Corticosteroids 3

Coming up

10phase 3 studies under way
40studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 116 Cardiomyopathies studies recruiting now, 71 (61%) set no upper age limit and 17 (15%) stop at 75 or younger. 36 (31%) take children under 18. 2 (2%) are for women only and 5 (4%) for men only; 22 (19%) take healthy volunteers.

Recruiting studies that take each age, of 116
AgeWomenMen
1022 (19%)27 (23%)
18105 (91%)108 (93%)
30105 (91%)106 (91%)
40104 (90%)105 (91%)
50104 (90%)105 (91%)
65102 (88%)103 (89%)
7599 (85%)100 (86%)
8585 (73%)86 (74%)

Across all 553 studies, recruiting or not: 22% stop at 75 or younger and 16% at 65; 23% take children; 3% are for women only and 5% for men only; 15% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Cardiomyopathies studies take

Of 20 phase 3 interventional studies under Cardiomyopathies, half reached primary completion within 57 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 139 mo26–58 · 16 studies——
Phase 357 mo49–103 · 20 studies——
Interventional, no phase39 mo23–52 · 51 studies—35 mo21–53 · 40 studies
Observational83 mo34–… · 140 studies—87 mo34–… · 119 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting1

Results posted2

Stopped1

Newly registered3

Studies

Recruiting first, then most recently updated. Showing 50 of 553. Browse all 553 → or search them.